Shorter TB‑Treatments Win Over Doctors and Nurses

In South Africa, the fight against tuberculosis relies on three main tools, one of which is preventive therapy. Yet many people never start or finish the course. A recent study in Johannesburg and Limpopo examined why health workers choose one medication mix over another.

Study Design

• Participants: 28 doctors, pharmacists and nurses
• Period: April – December 2022
• Method: Semi‑structured interviews
• Focus: Two common regimens
• Isoniazid + Rifapentine
• Isoniazid + Rifampicin

Key Findings

Despite these priorities, real‑world clinic conditions—staff shortages, long waiting lines, patient drop‑outs, and paperwork gaps—impede treatment.

Barriers to Uptake

• Patient Knowledge Gap: Limited educational resources and brief interactions mean patients often don’t grasp the benefits of preventive therapy.
• Provider Time Constraints: When doctors have more time to explain treatment plans, prescription rates and adherence improve.

Practical Recommendations

1. Regular Staff Training

   • Keep clinicians up‑to‑date on the latest drug options and protocols.

2. Clear Counseling Materials

   • Provide patient‑friendly handouts that explain benefits, dosing schedules, and side‑effect management.

3. Accurate Record Keeping

   • Maintain detailed treatment logs to track patient progress and identify gaps early.

Implementing these steps could significantly increase the number of people who start and complete TB preventive therapy, ultimately reducing disease burden across South Africa.